Mylan Raises Offer for Perrigo Again and Is Rejected Again

Seeking to fend off an unwanted bid from Teva, Mylan increased its cash-and-stock offer for Perrigo.








from NYT > Health http://ift.tt/1ET88tx
via health&fitness